E7386 enhances lenvatinib’s antitumor activity in preclinical models and human hepatocellular carcinoma.
Direct links to NCBI, no account and no request form: the whole study as GSE299215_RAW.tar, processed values as the series matrix, the supplementary file directory, and per-sample supplementary files for any of the 44 samples. Raw sequencing reads are also available from ENA.
Also filed as BioProject PRJNA1273097 and SRA study SRP590410. Searching any of these in the dataset finder brings you back here.
Supports a between-group comparison across 38 samples.
10 replicated groups read from the first 40 of 44 sample titles; they account for 38 of them. Check it against the sample list below before relying on it.
- GSM9035232 Huh7, DMSO-treated, 1
- GSM9035233 Huh7, DMSO-treated, 2
- GSM9035234 Huh7, DMSO-treated, 3
- GSM9035235 Huh7, DMSO-treated, 4
- GSM9035236 Huh7, E7386-treated, 1
- GSM9035237 Huh7, E7386-treated, 2
- GSM9035238 Huh7, E7386-treated, 3
- GSM9035239 Huh7, E7386-treated, 4
- GSM9035240 SNU398, DMSO-treated, 1
- GSM9035241 SNU398, DMSO-treated, 2
- GSM9035242 SNU398, DMSO-treated, 3
- GSM9035243 SNU398, DMSO-treated, 4
- GSM9035244 SNU398, E7386-treated, 1
- GSM9035245 SNU398, E7386-treated, 2
- GSM9035246 SNU398, E7386-treated, 3
- GSM9035247 SNU398, E7386-treated, 4
- GSM9035248 Hep3B, DMSO-treated, 1
- GSM9035249 Hep3B, DMSO-treated, 2
- GSM9035250 Hep3B, DMSO-treated, 3
- GSM9035251 Hep3B, DMSO-treated, 4
- GSM9035252 Hep3B, E7386-treated, 1
- GSM9035253 Hep3B, E7386-treated, 2
- GSM9035254 Hep3B, E7386-treated, 3
- GSM9035255 Hep3B, E7386-treated, 4
- GSM9035256 SNU387, DMSO-treated, 1
- GSM9035257 SNU387, DMSO-treated, 2
- GSM9035258 SNU387, DMSO-treated, 3
- GSM9035259 SNU387, DMSO-treated, 4
- GSM9035260 SNU387, E7386-treated, 1
- GSM9035261 SNU387, E7386-treated, 2
- GSM9035262 SNU387, E7386-treated, 3
- GSM9035263 SNU387, E7386-treated, 4
- GSM9035264 MYC-lucOS;CTNNB1 overexpression, C57BL6/J, Vehicle, 1
- GSM9035265 MYC-lucOS;CTNNB1 overexpression, C57BL6/J, Vehicle, 2
- GSM9035266 MYC-lucOS;CTNNB1 overexpression, C57BL6/J, Vehicle, 3
- GSM9035267 MYC-lucOS;CTNNB1 overexpression, C57BL6/J, Lenvatinib, 1
- GSM9035268 MYC-lucOS;CTNNB1 overexpression, C57BL6/J, Lenvatinib, 2
- GSM9035269 MYC-lucOS;CTNNB1 overexpression, C57BL6/J, Lenvatinib, 3
- GSM9035270 MYC-lucOS;CTNNB1 overexpression, C57BL6/J, E7386, 1
- GSM9035271 MYC-lucOS;CTNNB1 overexpression, C57BL6/J, E7386+Lenvatinib, 1
+ 4 more — browse all 44 samples with per-sample file links →
- GSE246221 A Mouse Model for Metabolic Dysfunction-associated Steatotic Liver Disease and Hepatocellular Carcinoma [RNA-seq] 148 samples
- GSE255972 The oncolytic adenovirus Delta-24-RGD in combination with ONC201 induces a potent antitumor response in pediatric high-grade and diffuse midline glioma models 64 samples
- GSE294355 Dual function of DOT1L suppresses tumor intrinsic immunogenicity in Hepatocellular carcinoma [RNA-seq] 36 samples
- GSE336821 Establishment and characterization of patient-derived in-vitro and in-vivo models of penile squamous cell carcinoma 10 samples
- GSE277025 Inhaled Xenon modulates microglia and ameliorates disease in mouse models of amyloidosis and tauopathy 192 samples
- GSE296402 Interleukin-23 promotes a pro-inflammatory Th17 cell state by stabilizing RORγt and suppressing glucocorticoid receptor activity 66 samples
- GSE316054 Targeting the ADAR1 p150 isoform triggers tumor growth inhibition and antitumor immunity to overcome immunotherapy resistance 52 samples
- GSE282369 Metformin enhances human oligodendrocyte function by altering metabolism 17 samples
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.